| Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products P Pandi, R Bulusu, N Kommineni, W Khan, M Singh International journal of pharmaceutics 586, 119560, 2020 | 232 | 2020 |
| Microneedle-based natural polysaccharide for drug delivery systems (DDS): progress and challenges F Damiri, N Kommineni, SO Ebhodaghe, R Bulusu, VGSS Jyothi, ... Pharmaceuticals 15 (2), 190, 2022 | 65 | 2022 |
| Stability characterization for pharmaceutical liposome product development with focus on regulatory considerations: An update VGSS Jyothi, R Bulusu, BVK Rao, M Pranothi, S Banda, PK Bolla, ... International Journal of Pharmaceutics 624, 122022, 2022 | 44 | 2022 |
| Recent advances in adsorptive nanocomposite membranes for heavy metals ion removal from contaminated water: A comprehensive review F Damiri, S Andra, N Kommineni, SK Balu, R Bulusu, AA Boseila, ... Materials 15 (15), 5392, 2022 | 39 | 2022 |
| Nanotechnology for biomedical applications SR Pasika, R Bulusu, BVK Rao, N Kommineni, PK Bolla, SG Kala, ... Nanomaterials: Advances and Applications, 297-327, 2023 | 6 | 2023 |
| Evaluation of anticancer activity of Zhubech, a New 5-FU analog liposomal formulation, against pancreatic cancer NB Ndemazie, R Bulusu, XY Zhu, EK Frimpong, A Inkoom, J Okoro, ... International Journal of Molecular Sciences 24 (5), 4288, 2023 | 4 | 2023 |
| Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer A Inkoom, NB Ndemazie, T Smith, E Frimpong, R Bulusu, R Poku, X Zhu, ... BMC cancer 23 (1), 435, 2023 | 3 | 2023 |
| Synthesis, characterization, and anticancer evaluation of 1, 3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer NB Ndemazie, A Inkoom, D Ebesoh, R Bulusu, E Frimpong, J Trevino, ... BMC cancer 22 (1), 1345, 2022 | 1 | 2022 |
| Application of modified gemcitabine-loaded solid lipid nanoparticle in the treatment of pancreatic cancer patient-derived xenograft model A Inkoom, N Ndemazie, T Smith, E Frimpong, R Bulusu, R Poku, X Zhu, ... | 1 | 2022 |
| Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancer E Frimpong, R Bulusu, J Okoro, A Inkoom, N Ndemazie, S Rogers, X Zhu, ... European Journal of Pharmaceutical Sciences 196, 106754, 2024 | | 2024 |
| Synthesis and biological evaluation of novel 5-FU analogs against pancreatic cancer E Frimpong, R Bulusu, J Okoro, A Inkoom, N Ndemazie, S Rogers, X Zhu, ... Cancer Research 84 (6_Supplement), 1825-1825, 2024 | | 2024 |
| Development and evaluation of novel gemcitabine analog for the treatment of pancreatic cancer J Okoro, R Bulusu, EK Frimpong, S Rodgers, B Han, X Zhu, E Agyare Cancer Research 84 (6_Supplement), 1828-1828, 2024 | | 2024 |
| In vitro evaluation of novel pyrimidine nucleosides for the treatment of pancreatic cancer R Bulusu, J Okoro, E Frimpong, B Han, S Rogers, X Zhu, E Agyare Cancer Research 84 (6_Supplement), 1823-1823, 2024 | | 2024 |
| Characterization and evaluation of modified 5-fluorouracil loaded liposomal nanoparticle on pancreatic and colorectal cancer cell lines R Bulusu, NB Ndemazie, EK Frimpong, A Inkoom, JC Okoro, XY Zhu Cancer Research 83 (7_Supplement), 839-839, 2023 | | 2023 |
| Biological evaluation of novel stearoyl gemcitabine nanoparticles in primary pancreatic cancer cells and PDX mice tumor models EK Frimpong, A Inkoom, NB Ndemazie, R Bulusu, JC Okoro, B Han, ... Cancer Research 83 (7_Supplement), 816-816, 2023 | | 2023 |
